Interferon beta-1a Completed Phase 4 Trials for Relapsing Multiple Sclerosis (RMS) / Clinically Isolated Syndrome (CIS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02254304Effectiveness of Rebif® in Clinically Isolated Syndrome and Relapsing Multiple Sclerosis Using RebiSmart™ (PROCEED)